Literature DB >> 23607421

USA300 methicillin-resistant Staphylococcus aureus in Norway.

Aina E Fossum Moen1, Tone Møller Tannaes, Truls Michael Leegaard.   

Abstract

Moen AEF*, Tannaes TM, Leegaard TM. USA300 methicillin-resistant Staphylococcus aureus (MRSA) in Norway. Community-associated methicillin-resistant S. aureus USA300 is known for its ability to disseminate and colonize and the clone has been detected globally. We studied the most populated area in Norway in search for the strain and for signs of endemic establishment. Strain typing techniques such as spa-, SCCmec- and dru-typing, pulsed-field gel electrophoresis and detection of USA300 molecular markers, lukS/F-PV and arcA, were performed. USA300 has been present in the study area since 2003 and has increased in incidence in parallel with the total MRSA incidence. Most USA300 isolates were found in the community, but isolates were also detected in health care institutions.
© 2013 APMIS Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Time trend analysis; antibiotic resistance; molecular epidemiology

Mesh:

Year:  2013        PMID: 23607421     DOI: 10.1111/apm.12077

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Eriodictyol protects against Staphylococcus aureus-induced lung cell injury by inhibiting alpha-hemolysin expression.

Authors:  He Xuewen; Ouyang Ping; Yuan Zhongwei; Yin Zhongqiong; Fu Hualin; Lin Juchun; He Changliang; Shu Gang; Yuan Zhixiang; Song Xu; Zou Yuanfeng; Li Lixia; Yin Lizi
Journal:  World J Microbiol Biotechnol       Date:  2018-04-18       Impact factor: 3.312

2.  USA300, A strain of community-associated methicillin-resistant Staphylococcus aureus, crossing Belgium's borders: outbreak of skin and soft tissue infections in a hospital in Belgium.

Authors:  K Kaïret; E Ho; D Van Kerkhoven; J Boes; S Van Calenbergh; L Pattyn; P Lemay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-03       Impact factor: 3.267

Review 3.  Studying the time trend of Methicillin-resistant Staphylococcus aureus (MRSA) in Norway by use of non-stationary γ-Poisson distributions.

Authors:  John F Moxnes; Aina E Fossum Moen; Truls Michael Leegaard
Journal:  BMJ Open       Date:  2015-10-05       Impact factor: 2.692

Review 4.  Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review.

Authors:  Shima M Abdulgader; Adebayo O Shittu; Mark P Nicol; Mamadou Kaba
Journal:  Front Microbiol       Date:  2015-04-30       Impact factor: 5.640

5.  MRSA infections in Norway: A study of the temporal evolution, 2006-2015.

Authors:  Francesco Di Ruscio; Jørgen Vildershøj Bjørnholt; Truls Michael Leegaard; Aina E Fossum Moen; Birgitte Freiesleben de Blasio
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

6.  USA300 methicillin-resistant Staphylococcus aureus in Stockholm, Sweden, from 2008 to 2016.

Authors:  Josefine Enström; Inga Fröding; Christian G Giske; Karolina Ininbergs; Xiangning Bai; Gustaf Sandh; Ulla-Britt Tollström; Måns Ullberg; Hong Fang
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

7.  Subinhibitory Concentrations of Prim-O-Glucosylcimifugin Decrease the Expression of Alpha-Hemolysin in Staphylococcus aureus (USA300).

Authors:  Ouyang Ping; Yang Ruixue; Deng Jiaqiang; Wang Kaiyu; Fang Jing; Geng Yi; Huang Xiaoli; Chen Defang; Lai Weimin; Tang Li; Yin Lizi
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-19       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.